Leber's Hereditary Optic Neuropathy Clinical Trial
Official title:
A Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Patients With Leber's Hereditary Optic Neuropathy
This study is meant to assess the effectiveness of idebenone on visual function measures in patients with Leber's Hereditary Optic Neuropathy over a 6 months period.
The study involves 6 clinic visits. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01421381 -
RHODOS Follow-up Single-visit Study
|
N/A | |
| Completed |
NCT04909398 -
Pupil Dynamics and Color Vision for the Detection of Eye Diseases
|
N/A | |
| Completed |
NCT02693119 -
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy
|
Phase 2 | |
| Active, not recruiting |
NCT02161380 -
Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy
|
Phase 1 | |
| No longer available |
NCT04381091 -
Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study
|
||
| No longer available |
NCT02300753 -
Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]
|
N/A | |
| Withdrawn |
NCT01495715 -
Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
|
Phase 3 |